Non-Hodgkin’s lymphoma (NHL) is a diverse group of cancers that develops in lymphocytes, a type of white blood cell involved in the immune system. These cancers can develop in lymph nodes and other tissues throughout the body.

Non-Hodgkin’s lymphoma includes many different subtypes with distinct biological characteristics, growth patterns, and treatment responses. Some forms grow slowly, while others can progress rapidly.

Because of this biological diversity, research into NHL requires access to well-characterized human tissue specimens that represent different disease subtypes, stages, and clinical characteristics.

At Bay Biosciences, we provide high-quality Non-Hodgkin’s Lymphoma Samples that support research, drug discovery, diagnostics development, and translational studies.

Understanding Non-Hodgkin's Lymphoma

Non-Hodgkin’s lymphoma begins in lymphocytes, which are part of the body’s lymphatic and immune systems. These abnormal cells can accumulate in lymph nodes or other tissues and form tumors.

NHL is not a single disease. Instead, it includes a large number of lymphoma subtypes that can originate from B lymphocytes or T lymphocytes.

This diversity makes Non-Hodgkin’s Lymphoma Tissue Samples particularly valuable for research because samples from different subtypes can help investigators study disease-specific molecular pathways and treatment responses.

Non-Hodgkins Lymphoma Tissue Samples

Types of Non-Hodgkin's Lymphoma

Non-Hodgkin’s lymphoma can be classified according to the type of lymphocyte involved and how quickly the cancer grows.

The major categories include:

  • B-cell lymphomas, which develop from abnormal B lymphocytes
  • T-cell lymphomas, which develop from abnormal T lymphocytes
  • Indolent lymphomas, which generally grow slowly
  • Aggressive lymphomas, which generally grow and spread more rapidly

Examples include: diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, Burkitt lymphoma, and several types of T-cell lymphoma.

Symptoms of Non-Hodgkin's Lymphoma

The symptoms of NHL vary depending on the subtype, location, tumor size, and rate of growth. Some people may have few or no symptoms during the early stages.

Common symptoms include:

Risk Factors for Non-Hodgkin's Lymphoma

The exact cause of most NHL cases remains unknown. However, researchers have identified several factors that may increase the risk of developing the disease.

These include:

Having a risk factor does not mean that a person will develop NHL. Many individuals diagnosed with the disease have no clearly identifiable risk factor.

Causes of Non-Hodgkin's Lymphoma

Researchers believe that changes in the DNA of lymphocytes play an important role in the development of NHL.

These genetic changes can affect the normal processes that control cell growth, division, and cell death.

Changes in the immune system may also contribute to lymphoma development.

For example, conditions that cause prolonged immune activation or weaken immune function can increase the likelihood of certain NHL subtypes.

Certain infections have also been associated with specific types of NHL.

However, the biological mechanisms involved can differ significantly between lymphoma subtypes.

Diagnosis of Non-Hodgkin's Lymphoma

Healthcare providers use several tests to diagnose and classify NHL. The diagnostic process generally begins with a physical examination and review of the patient’s medical history.

Doctors may evaluate enlarged lymph nodes and check for other signs of disease. Blood tests can provide information about overall health and blood cell counts.

Imaging tests such as CT, PET, or MRI scans may help determine where lymphoma is located and whether it has spread to other parts of the body.

A biopsy is often essential for confirming lymphoma and identifying its specific subtype. During a biopsy, a tissue sample is removed and examined by a pathologist.

Additional laboratory techniques can then be used to characterize the lymphoma cells.

Staging of Non-Hodgkin's Lymphoma

After NHL is diagnosed, doctors determine the extent of the disease through staging.

Staging helps healthcare providers understand where the lymphoma is located and whether it has spread beyond its original site.

The stage may be determined using:

The stage, lymphoma subtype, tumor characteristics, and patient’s overall health can all influence treatment decisions and prognosis.

Treatment of Non-Hodgkin's Lymphoma

Treatment for Non-Hodgkin’s lymphoma depends on several factors, including the type and stage of lymphoma, how quickly the cancer is growing, the patient’s overall health, and whether the cancer has spread to other parts of the body.

Doctors may use one treatment alone or combine several approaches to control the disease and reduce the risk of recurrence.

For slow-growing types of Non-Hodgkin’s lymphoma, doctors may recommend active surveillance when the cancer does not cause symptoms or require immediate treatment.

During active surveillance, the healthcare team regularly monitors the patient’s condition through physical examinations, blood tests, imaging scans, and other assessments.

Moreover, Chemotherapy is another common treatment for non-Hodgkin lymphoma. It uses medicines that destroy cancer cells or slow their growth.

Doctors may use chemotherapy alone or combine it with other treatments, such as immunotherapy or radiation therapy, depending on the lymphoma subtype and stage.

Furthermore, for some patients with aggressive or relapsed Non-Hodgkin’s lymphoma, doctors may recommend a stem cell transplant.

Role of Lymphoma Tissue Samples in Research

Lymphoma Tissue Samples provide researchers with direct access to the tumor microenvironment and malignant cells involved in NHL.

Researchers can use these samples to investigate:

  • Lymphoma cell biology
  • Histological characteristics
  • Genetic and molecular alterations
  • Tumor heterogeneity
  • Immune cell interactions
  • Biomarker expression
  • Treatment resistance
  • Disease progression
  • New therapeutic targets

Frequently Asked Questions

What are Non-Hodgkin’s Lymphoma Tissue Samples used for?

Non-Hodgkin’s Lymphoma Tissue Samples support research into lymphoma biology, tumor characteristics, genetic and molecular alterations, disease progression, biomarkers, and treatment responses. 

What are Fresh Frozen Tissue Samples used for?

Fresh Frozen Tissue Samples can support molecular, genomic, biomarker, and translational research where preservation of tissue components is important.

Why are Human Tumor Tissue Samples valuable in lymphoma research?

Human Tumor Tissue Samples preserve important characteristics of the original tumor and allow researchers to investigate tumor biology, cellular interactions, molecular alterations, and treatment-related changes.

Are Non-Hodgkin’s Lymphoma Tissue Samples collected ethically?

Yes. All biospecimens are collected under IRB-approved protocols with informed consent and complete donor de-identification to ensure ethical and regulatory compliance.

Supporting Your Research with Bay Biosciences

Bay Biosciences provides high-quality, clinical-grade human biospecimens for pharmaceutical companies, biotechnology organizations, academic institutions, and diagnostic developers.

Our comprehensive collection of biospecimens includes:

If you have any questions, concerns, or special requests, please don’t hesitate to contact us.